María Ángeles Jiménez-Fuentes

Author

Also Known As

M Ángeles Jiménez-Fuentes, M. A. Jiménez-Fuentes, M. Ángeles Jiménez-Fuentes, M. Ãngeles Jimenez-Fuentes, M.A. Jiménez-Fuentes, M.Á. Jiménez-Fuentes, Maria Angeles Jiménez-Fuentes, María A. Jiménez-Fuentes, María Á. Jiménez-Fuentes, María Ángeles Jiménez-Fuentes

Publications

513

Citations

H-Index

Concepts

All Affiliations

Vall d'Hebron Hospital Universitari Universitat Autònoma de Barcelona Centro de Investigación Biomédica en Red de Enfermedades Respiratorias Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

MÁ

About

María Ángeles Jiménez-Fuentes is an author at Vall d'Hebron Hospital Universitari specializing in tuberculosis, epidemiology, and tuberculosis prevention.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	76
2	Public Health	1	1	76
3	Epidemiology	1	1	76
4	Tuberculosis	1	1	76
5	Covid-19	1	1	76

María Ángeles Jiménez-Fuentes

Publications

456

Citations

H-Index

Page 1

	Year	Citations
Impact of the COVID-19 pandemic on tuberculosis management in Spain María Luisa Aznar, Juan Espinosa‐Pereiro, Núria Saborit, International Journal of Infectious Diseases MedicineTuberculosis PreventionCovid-19 PandemicTuberculosisDisease Outbreak	2021	76
Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis Máμƒdel Mar Serra-Vidal, Irene Latorre, Kees L. M. C. Franken, Frontiers in Microbiology	2014	75
Assessment of the influence of direct tobacco smoke on infection and active TB management Neus Altet, Irene Latorre, María Ángeles Jiménez-Fuentes, PLoS ONE	2017	50
Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population María Ángeles Jiménez-Fuentes, María Luiza de Souza-Galvão, Celia Milà Augé, The International Journal of Tuberculosis and Lung Disease	2013	44
Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker José Luis Izquierdo-García, Patricia Comella-del-Barrio, Ramón Campos‐Olivas, Scientific Reports	2020	42
Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing Neus Altet, José Domínguez, María Luiza de Souza-Galvão, Annals of the American Thoracic Society	2015	40
Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management Irene Latorre, Marco A. Fernández, Beatriz Muriel-Moreno, Frontiers in Immunology	2019	31
Screening for active tuberculosis in high-risk groups María Ángeles Jiménez-Fuentes, Celia Milà Augé, Ma Nieves Gómez, The International Journal of Tuberculosis and Lung Disease	2014	29
Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment Teresa Rodrigo, Martí Casals, José A. Caminero, PLoS ONE	2016	22
Factors associated with smoking among tuberculosis patients in Spain María Ángeles Jiménez-Fuentes, Teresa Rodrigo, M.N. Altet, BMC Infectious Diseases	2016	22

Page 1